Concomitant EGFR mutations/ALK rearrangements: beyond a simple dual target

Ítems similars

• Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report
  per: Fan, Jun, et al.
  Publicat: (2020)
• Metachronous primary uterine cancer surgically resected during Crizotinib treatment in a ALK-rearranged advanced lung adenocarcinoma
  per: Catino, Annamaria, et al.
  Publicat: (2016)
• Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
  per: Yamaguchi, Norihiro, et al.
  Publicat: (2013)
• Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
  per: Gkolfinopoulos, Stavros, et al.
  Publicat: (2018)
• Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
  per: Marino, Federica Zito, et al.
  Publicat: (2015)